Booster Vaccine Platform Shapes the Breadth and Durability of SARS-CoV-2 T-Cell Immunity
A nine-month Ghanaian cohort study finds that adenoviral-vector boosting sustains broader and more durable SARS-CoV-2 T-cell epitope recognition than mRNA ...
A nine-month Ghanaian cohort study finds that adenoviral-vector boosting sustains broader and more durable SARS-CoV-2 T-cell epitope recognition than mRNA ...
A phase IV trial in Indian infants and toddlers found the WHO-prequalified 14-valent pneumococcal conjugate vaccine PNEUBEVAX 14 was well ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine